ClinVar Miner

Submissions for variant NM_015450.3(POT1):c.1007-2_1009del

dbSNP: rs754005964
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001016971 SCV001177984 uncertain significance Hereditary cancer-predisposing syndrome 2021-03-09 criteria provided, single submitter clinical testing The c.1007-2_1009delAGTAC variant results from a deletion of 5 nucleotides between positions c.1007-2 and c.1009 and involves the canonical splice acceptor site before coding exon 9 of the POT1 gene. The canonical splice acceptor site is well conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to lead to the creation of a new in-frame alternate splice acceptor site that would remove only three amino acids from the protein; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.